Anixa Biosciences, Inc , a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced that the U.S. Patent and Trademark...
Regen BioPharma, Inc. is embarking on a development program to commercialize its modified mRNA anti-cancer vaccine targeting the Survivin protein. In the first phase...
